71 related articles for article (PubMed ID: 20148381)
1. [Prognostic factors from a long-term follow-up of heroin-assisted treatment in Switzerland 1994-2007].
Frick U; Wiedermann W; Schaub M; Uchtenhagen A; Rehm J
Psychiatr Prax; 2010 May; 37(4):175-82. PubMed ID: 20148381
[TBL] [Abstract][Full Text] [Related]
2. [Heroin-assisted treatment of opiate addicts--former and current research emphasis].
Steffen T; Kaufmann B; Blättler R; Dobler-Mikola A; Gutzwiller F; Uchtenhagen A
Gesundheitswesen; 1999; 61(8-9):407-12. PubMed ID: 10535222
[TBL] [Abstract][Full Text] [Related]
3. [Economic evaluation of the Swiss project on medically prescribed heroin substitution treatment].
Frei A
Psychiatr Prax; 2001 Jul; 28 Suppl 1():S41-4. PubMed ID: 11533906
[No Abstract] [Full Text] [Related]
4. Mortality in heroin-assisted treatment in Switzerland 1994-2000.
Rehm J; Frick U; Hartwig C; Gutzwiller F; Gschwend P; Uchtenhagen A
Drug Alcohol Depend; 2005 Aug; 79(2):137-43. PubMed ID: 16002023
[TBL] [Abstract][Full Text] [Related]
5. Heroin-assisted treatment in Switzerland: a case study in policy change.
Uchtenhagen A
Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
[TBL] [Abstract][Full Text] [Related]
6. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
Goeb JL; Coste J; Bigot T; Ferrand I
Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
[TBL] [Abstract][Full Text] [Related]
7. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
8. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659
[TBL] [Abstract][Full Text] [Related]
9. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.
Schäfer I; Eiroa-Orosa FJ; Verthein U; Dilg C; Haasen C; Reimer J
Psychopathology; 2010; 43(2):88-95. PubMed ID: 20068379
[TBL] [Abstract][Full Text] [Related]
10. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study.
Rehm J; Gschwend P; Steffen T; Gutzwiller F; Dobler-Mikola A; Uchtenhagen A
Lancet; 2001 Oct; 358(9291):1417-23. PubMed ID: 11705488
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
12. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA;
Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028
[TBL] [Abstract][Full Text] [Related]
13. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
Frei A; Rehm J;
Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
[TBL] [Abstract][Full Text] [Related]
14. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year.
Soeffing JM; Martin LD; Fingerhood MI; Jasinski DR; Rastegar DA
J Subst Abuse Treat; 2009 Dec; 37(4):426-30. PubMed ID: 19553061
[TBL] [Abstract][Full Text] [Related]
16. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
17. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
Dolan KA; Shearer J; White B; Zhou J; Kaldor J; Wodak AD
Addiction; 2005 Jun; 100(6):820-8. PubMed ID: 15918812
[TBL] [Abstract][Full Text] [Related]
18. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment.
Dobler-Mikola A; Hättenschwiler J; Meili D; Beck T; Böni E; Modestin J
J Subst Abuse Treat; 2005 Dec; 29(4):259-65. PubMed ID: 16311178
[TBL] [Abstract][Full Text] [Related]
19. Seeing the trees despite the forest: applying recursive partitioning to the evaluation of drug treatment retention.
Hellemann G; Conner BT; Anglin MD; Longshore D
J Subst Abuse Treat; 2009 Jan; 36(1):59-64. PubMed ID: 18599252
[TBL] [Abstract][Full Text] [Related]
20. Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up.
Güttinger F; Gschwend P; Schulte B; Rehm J; Uchtenhagen A
Eur Addict Res; 2003 Apr; 9(2):73-9. PubMed ID: 12644733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
